BridgeBio is a biopharmaceutical company dedicated to discovering, developing, and delivering transformative medicines for patients living with genetic diseases and genetically defined cancers.
Director, Market Access Western Europe Region - Lead HTA, Pricing & Reimbursement, Clinical Development, Evidence Generation, and Other responsibilities to ensure pricing, reimbursement and optimal patient access to BridgeBio's medicines in France, Belgium, and the Netherlands.
BridgeBio is a biopharmaceutical company dedicated to discovering, developing, and delivering transformative medicines for patients living with genetic diseases and genetically defined cancers.
GSK